HRP20200450T1 - Topikalne farmaceutske formulacije koje sadrže nisku koncentraciju benzoil peroksida u suspenziji u vodi i organskog otapala topivog u vodi - Google Patents

Topikalne farmaceutske formulacije koje sadrže nisku koncentraciju benzoil peroksida u suspenziji u vodi i organskog otapala topivog u vodi Download PDF

Info

Publication number
HRP20200450T1
HRP20200450T1 HRP20200450TT HRP20200450T HRP20200450T1 HR P20200450 T1 HRP20200450 T1 HR P20200450T1 HR P20200450T T HRP20200450T T HR P20200450TT HR P20200450 T HRP20200450 T HR P20200450T HR P20200450 T1 HRP20200450 T1 HR P20200450T1
Authority
HR
Croatia
Prior art keywords
water
benzoyl peroxide
concentration
formulation
propylene glycol
Prior art date
Application number
HRP20200450TT
Other languages
English (en)
Croatian (hr)
Inventor
Gordon J. Dow
Yunik Chang
Original Assignee
Bausch Health Ireland Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41398394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20200450(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bausch Health Ireland Limited filed Critical Bausch Health Ireland Limited
Publication of HRP20200450T1 publication Critical patent/HRP20200450T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/33—Free of surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20200450TT 2008-06-05 2009-06-03 Topikalne farmaceutske formulacije koje sadrže nisku koncentraciju benzoil peroksida u suspenziji u vodi i organskog otapala topivog u vodi HRP20200450T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13101408P 2008-06-05 2008-06-05
EP09758748.9A EP2299810B1 (en) 2008-06-05 2009-06-03 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
PCT/US2009/003367 WO2009148584A1 (en) 2008-06-05 2009-06-03 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

Publications (1)

Publication Number Publication Date
HRP20200450T1 true HRP20200450T1 (hr) 2020-06-26

Family

ID=41398394

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200450TT HRP20200450T1 (hr) 2008-06-05 2009-06-03 Topikalne farmaceutske formulacije koje sadrže nisku koncentraciju benzoil peroksida u suspenziji u vodi i organskog otapala topivog u vodi

Country Status (15)

Country Link
US (13) US8288434B2 (OSRAM)
EP (1) EP2299810B1 (OSRAM)
JP (2) JP5677693B2 (OSRAM)
KR (1) KR20110014651A (OSRAM)
CN (1) CN102056481A (OSRAM)
AU (1) AU2009255679B2 (OSRAM)
BR (1) BRPI0913326C1 (OSRAM)
CA (1) CA2723029C (OSRAM)
ES (1) ES2773931T3 (OSRAM)
HR (1) HRP20200450T1 (OSRAM)
MX (1) MX2010013152A (OSRAM)
PT (1) PT2299810T (OSRAM)
RU (2) RU2493847C2 (OSRAM)
WO (1) WO2009148584A1 (OSRAM)
ZA (1) ZA201008265B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1919606A2 (en) 2005-08-02 2008-05-14 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
EP2545776A3 (en) 2007-02-01 2014-12-24 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
CN102056481A (zh) * 2008-06-05 2011-05-11 陶氏制药科学公司 包含低浓度的在水和水混溶性有机溶剂中的悬浮液形式的过氧苯甲酰的局部药物制剂
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US20100099733A1 (en) * 2008-10-20 2010-04-22 Gordon Jay Dow Method for obtaining a stable dispersion of benzoyl peroxide
MX350488B (es) * 2009-10-21 2017-09-07 Dow Pharmaceutical Sciences Metodo para humectar un polvo que contiene peroxido de benzoilo.
US9744150B2 (en) * 2009-10-21 2017-08-29 Dow Pharmaceutical Sciences Inc. Suspension containing micronized benzoyl peroxide
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
CA2889199C (en) * 2012-11-27 2020-05-19 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2017068673A1 (ja) * 2015-10-21 2017-04-27 マルホ株式会社 皮膚用の医薬組成物
CN107304177B (zh) * 2016-04-20 2020-09-15 武汉诺安药业有限公司 一种过氧苯甲酰微粉化的化学制备方法
EP3651756B1 (en) 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
JP2020527607A (ja) * 2017-07-21 2020-09-10 アルミラール・リミテッド・ライアビリティ・カンパニーＡｌｍｉｒａｌｌ， Ｌｌｃ 非炎症性病変の処置
CN107375209A (zh) * 2017-08-30 2017-11-24 江苏嘉逸医药有限公司 一种过氧苯甲酰的局部药物制剂
CN107737135A (zh) * 2017-11-28 2018-02-27 江苏万川医疗健康产业集团有限公司 一种药物制剂及其制备方法与应用
JP6811213B2 (ja) * 2018-07-03 2021-01-13 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
US10933046B2 (en) * 2019-02-19 2021-03-02 Sol-Gel Technologies, Ltd. Method for treatment of rosacea in patients aged 65 years and older
MX2022001138A (es) * 2019-08-01 2022-02-16 Bausch Health Ireland Ltd Composiciones topicas.
CN113577022B (zh) * 2021-05-18 2023-03-17 南京欣通瑞亿医药科技有限公司 一种氨苯砜类化合物混悬液及其制备方法和应用
EP4523677A1 (en) 2023-09-13 2025-03-19 Dr. Pfleger Arzneimittel GmbH Topical composition of nadifloxacin and benzoyl peroxide

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535442A (en) 1967-10-19 1970-10-20 John E Jennings Anti-shoplifting and surveillance system
US4056611A (en) 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US4497794A (en) * 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4075353A (en) 1976-06-09 1978-02-21 Dermatologics For Veterinary Medicine, Inc. Process for the treatment of acarid skin infections in animals
FR2378523A1 (fr) 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
US4189501A (en) 1977-10-07 1980-02-19 A. H. C. Pharmacal, Inc. Composition and method for the treatment of acne
US4387107A (en) 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
NZ194326A (en) 1979-07-25 1982-05-31 Dermik Lab Inc Stable aqueous benzoyl peroxide compositions and therapeutic compositions
IT1210608B (it) * 1980-12-08 1989-09-14 Rorer Int Overseas Composizione per il trattamento topico dell'acne
US4411893A (en) 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4401835A (en) 1981-09-17 1983-08-30 Warner-Lambert Company Method for preparing small sized benzoyl peroxide crystals
US4923900A (en) 1985-01-24 1990-05-08 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
FR2604435B1 (fr) 1986-09-30 1988-12-02 Oreal Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6117843A (en) 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
IL105217A0 (en) 1992-04-09 1993-07-08 Allergan Inc Method and composition for treating acne
US5466446A (en) 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5470884A (en) 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
DE4418096A1 (de) 1994-05-24 1995-11-30 Cassella Ag Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase
US5445823A (en) 1994-10-20 1995-08-29 The Procter & Gamble Company Dermatological compositions and method of treatment of skin lesions therewith
US20020039561A1 (en) 1995-11-15 2002-04-04 Doughty Darrell Gene Topical skin care compositions containing thickened polyol carboxylic acid esters as skin conditioning agents
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6433024B1 (en) 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6837383B1 (en) 2001-01-25 2005-01-04 Mcelhaney Jr Wayne Tool organizer mounted to a vehicle lift rack
US20030064084A1 (en) 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US20040101566A1 (en) 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
AR042906A1 (es) 2003-01-24 2005-07-06 Connetics Australia Pty Ltd Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
US20050239723A1 (en) * 2004-04-27 2005-10-27 Amin Avinash N Compositions and methods useful for treatment of acne
US7153888B2 (en) 2004-12-21 2006-12-26 Alpharx Inc. Stabilization of benzoyl peroxide in solution
WO2006099187A2 (en) 2005-03-10 2006-09-21 Jr Chem, Llc Benzoyl peroxide compositions and methods of use
AR054805A1 (es) 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
EP2206494B1 (en) 2006-03-31 2015-12-02 Stiefel Research Australia Pty Ltd Foamable suspension gel
MXPA06008988A (es) 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
EP1967180A1 (de) 2007-03-06 2008-09-10 Almirall Hermal GmbH Topische Zusammensetzung enthaltend einen Retinoid-Rezeptor-Agonist
CN102056481A (zh) * 2008-06-05 2011-05-11 陶氏制药科学公司 包含低浓度的在水和水混溶性有机溶剂中的悬浮液形式的过氧苯甲酰的局部药物制剂
KR102099993B1 (ko) * 2011-12-09 2020-04-10 마리 케이 인코포레이티드 피부 케어 제형물
US20200297684A1 (en) * 2019-03-18 2020-09-24 Bausch Health Ireland Limited Topical compositions and methods for treating acne vulgaris

Also Published As

Publication number Publication date
US20130012460A1 (en) 2013-01-10
US11478498B2 (en) 2022-10-25
JP6006272B2 (ja) 2016-10-12
MX2010013152A (es) 2011-05-02
RU2013122395A (ru) 2014-11-20
JP2011522820A (ja) 2011-08-04
US9561208B2 (en) 2017-02-07
WO2009148584A1 (en) 2009-12-10
US8895070B2 (en) 2014-11-25
US20140235560A1 (en) 2014-08-21
EP2299810B1 (en) 2020-01-01
CN102056481A (zh) 2011-05-11
ZA201008265B (en) 2011-08-31
US10220049B2 (en) 2019-03-05
AU2009255679A1 (en) 2009-12-10
US20170216336A1 (en) 2017-08-03
KR20110014651A (ko) 2011-02-11
JP5677693B2 (ja) 2015-02-25
JP2015038093A (ja) 2015-02-26
US20200276218A1 (en) 2020-09-03
US20170165220A1 (en) 2017-06-15
US8663699B2 (en) 2014-03-04
BRPI0913326B1 (pt) 2019-07-30
US20140050792A1 (en) 2014-02-20
US20140051649A1 (en) 2014-02-20
EP2299810A4 (en) 2013-11-13
US20090306172A1 (en) 2009-12-10
US9693988B2 (en) 2017-07-04
US10137142B2 (en) 2018-11-27
US20130236549A1 (en) 2013-09-12
CA2723029C (en) 2016-07-19
PT2299810T (pt) 2020-03-04
US20230047106A1 (en) 2023-02-16
RU2493847C2 (ru) 2013-09-27
BRPI0913326B8 (pt) 2019-09-03
US20160220528A1 (en) 2016-08-04
US10624918B2 (en) 2020-04-21
US20140134252A1 (en) 2014-05-15
US9504704B2 (en) 2016-11-29
ES2773931T3 (es) 2020-07-15
RU2645087C2 (ru) 2018-02-15
EP2299810A1 (en) 2011-03-30
AU2009255679B2 (en) 2015-04-09
US8288434B2 (en) 2012-10-16
US9078870B2 (en) 2015-07-14
US20190125776A1 (en) 2019-05-02
BRPI0913326C1 (pt) 2021-05-25
BRPI0913326A2 (pt) 2015-09-15
CA2723029A1 (en) 2009-12-10
RU2010146038A (ru) 2012-07-27

Similar Documents

Publication Publication Date Title
HRP20200450T1 (hr) Topikalne farmaceutske formulacije koje sadrže nisku koncentraciju benzoil peroksida u suspenziji u vodi i organskog otapala topivog u vodi
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
AR081789A1 (es) Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel
BR122017024704A8 (pt) Combinação sinérgica para uso na modulação da infecção fitopatogênica e método para modulação de infecção fitopatogênica em uma planta
BR112012002636A8 (pt) Microcápsulas contendo lactonas macrolídicas abamectina, milbemectina, avermectinas, milbemicinas, emamectinas, ivermectinas e mectinas em geral
MX369229B (es) Metodo para desinfectar semillas comestibles, particularmente semillas productoras de mucilago.
BR112012024674A2 (pt) grânulo, e, composição de detergente granular
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
CL2011002634A1 (es) Disolucion acuosa sin alcohol etilico que comprende propanolol o una sal farmaceuticamente aceptable del mismo, un edulcorante tipo no azucarado y menos del 0,01 % (p/v) de un agente conservante; procedimiento de preparacion; uso de la disolucion en el tratamiento de hemangiomas.
AR071123A1 (es) Composiciones para duchas y banos de inmersion
AR029655A1 (es) Mejoras en formulaciones en pasta
AR076127A1 (es) Formulacion
AR058821A1 (es) Metodos, sistemas y composiciones de tratamiento graduables por el usuario para el tratamiento del acne
CO6270298A2 (es) Composiciones para el cuidado del cabello/cuero cabelludo que comprende un surfactante y una mezcla eutecnica
PH12015501045A1 (en) Bpo wash gel composition
ATE447929T1 (de) Selbstbräuner enthaltend wasserlösliche vitamin b3-komponente und bräunungswirkstoff mit alpha- hydroxycarbonyl-gruppierung
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
AR052033A1 (es) Composicion farmaceutica que comprende inhibidor de topoisomerasa i
CO2022002253A2 (es) Composiciones topicas
AR069178A1 (es) Composiciones con agentes colorantes atipicos y metodo para impartir un aspecto saludable a la piel
CL2012000515A1 (es) Sustancia colorante dispersable en agua que comprende carbo vegetabilis y por lo menos 1% de un derivado de octenil succinato de almidón como agente dispersante; método de preparación de la sustancia colorante; su uso; y producto comestible y farmacéutico que lo contienen.
KR20170138178A (ko) 녹차유래 천연카페인 고함량 가용화 기술을 이용한 고기능성 화장품 조성물
PE20061365A1 (es) Composiciones farmaceuticas de liberacion modificada
AR063248A1 (es) Composiciones de blanqueo liquidas y acuosas
PE20240818A1 (es) Una composicion de rapamicina